How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies

Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer

Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to the clinic

Gilead gains accelerated FDA approval for rare liver disease treatment

FDA lifts hold on BioNTech and MediLink's ADC trial After safety revisions

Breakthrough delivery system could transform Alzheimer’s treatment

First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1

Breaking News: Lecanemab approved in UK but unavailable on NHS

Highlights

array(40) {
  [0]=>
  string(4) "9143"
  ["article_id"]=>
  string(4) "9143"
  [1]=>
  string(107) "Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call"
  ["article_title"]=>
  string(107) "Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call"
  [2]=>
  string(163) "BANNOCKBURN, Ill., Jan.  22, 2024  (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest indep"
  ["short_description"]=>
  string(163) "BANNOCKBURN, Ill., Jan.  22, 2024  (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest indep"
  [3]=>
  string(548) "
BANNOCKBURN, Ill., Jan.  22, 2024  (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.
"
  ["description"]=>
  string(548) "
BANNOCKBURN, Ill., Jan.  22, 2024  (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(179) "https://www.globenewswire.com/news-release/2024/01/22/2813464/0/en/Option-Care-Health-to-Announce-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Host-Conference-Call.html"
  ["blog_url"]=>
  string(179) "https://www.globenewswire.com/news-release/2024/01/22/2813464/0/en/Option-Care-Health-to-Announce-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Host-Conference-Call.html"
  [15]=>
  string(19) "2024-01-23 05:05:00"
  ["add_date"]=>
  string(19) "2024-01-23 05:05:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:29"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:29"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Hos

BANNOCKBURN, Ill., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Ca

array(40) {
  [0]=>
  string(4) "9117"
  ["article_id"]=>
  string(4) "9117"
  [1]=>
  string(88) "Amgen’s Osteoporosis Drug Prolia Gets Boxed Warning for Potential for Low Calcium"
  ["article_title"]=>
  string(88) "Amgen’s Osteoporosis Drug Prolia Gets Boxed Warning for Potential for Low Calcium"
  [2]=>
  string(153) "&#nl        A boxed warning has been added to the labeling for Prolia (denosumab) based on FDA review of information on the risk of severe hypocalcemia, "
  ["short_description"]=>
  string(153) "&#nl        A boxed warning has been added to the labeling for Prolia (denosumab) based on FDA review of information on the risk of severe hypocalcemia, "
  [3]=>
  string(243) "&#nl        A boxed warning has been added to the labeling for Prolia (denosumab) based on FDA review of information on the risk of severe hypocalcemia, very low blood calcium levels, in patients with advanced chronic kidney disease.&#nl      "
  ["description"]=>
  string(243) "&#nl        A boxed warning has been added to the labeling for Prolia (denosumab) based on FDA review of information on the risk of severe hypocalcemia, very low blood calcium levels, in patients with advanced chronic kidney disease.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(120) "https://www.fdanews.com/articles/213150-amgens-osteoporosis-drug-prolia-gets-boxed-warning-for-potential-for-low-calcium"
  ["blog_url"]=>
  string(120) "https://www.fdanews.com/articles/213150-amgens-osteoporosis-drug-prolia-gets-boxed-warning-for-potential-for-low-calcium"
  [15]=>
  string(19) "2024-01-23 04:10:28"
  ["add_date"]=>
  string(19) "2024-01-23 04:10:28"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:51"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Amgen’s Osteoporosis Drug Prolia Gets Boxed Warning for Potential for Low Calcium

&#nl A boxed warning has been added to the labeling for Prolia (denosumab) based on FDA review of information on 

array(40) {
  [0]=>
  string(4) "9118"
  ["article_id"]=>
  string(4) "9118"
  [1]=>
  string(88) "Novartis’ TV Ad for Kisqali Overstates Effectiveness, FDA Says in Untitled Letter"
  ["article_title"]=>
  string(88) "Novartis’ TV Ad for Kisqali Overstates Effectiveness, FDA Says in Untitled Letter"
  [2]=>
  string(153) "&#nl        The FDA has warned Novartis that its direct to consumer TV ad for its breast cancer drug Kisqali (ribociclib) makes false or misleading repre"
  ["short_description"]=>
  string(153) "&#nl        The FDA has warned Novartis that its direct to consumer TV ad for its breast cancer drug Kisqali (ribociclib) makes false or misleading repre"
  [3]=>
  string(247) "&#nl        The FDA has warned Novartis that its direct to consumer TV ad for its breast cancer drug Kisqali (ribociclib) makes false or misleading representations about the drug’s efficacy, sending the company an untitled letter.&#nl      "
  ["description"]=>
  string(247) "&#nl        The FDA has warned Novartis that its direct to consumer TV ad for its breast cancer drug Kisqali (ribociclib) makes false or misleading representations about the drug’s efficacy, sending the company an untitled letter.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(119) "https://www.fdanews.com/articles/213147-novartis-tv-ad-for-kisqali-overstates-effectiveness-fda-says-in-untitled-letter"
  ["blog_url"]=>
  string(119) "https://www.fdanews.com/articles/213147-novartis-tv-ad-for-kisqali-overstates-effectiveness-fda-says-in-untitled-letter"
  [15]=>
  string(19) "2024-01-23 03:30:34"
  ["add_date"]=>
  string(19) "2024-01-23 03:30:34"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:51"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Novartis’ TV Ad for Kisqali Overstates Effectiveness, FDA Says in Untitled Letter

&#nl The FDA has warned Novartis that its direct to consumer TV ad for its breast cancer drug Kisqali (ribociclib

array(40) {
  [0]=>
  string(4) "9218"
  ["article_id"]=>
  string(4) "9218"
  [1]=>
  string(76) "AI innovator talks personalized treatment, telehealth enhancement and ethics"
  ["article_title"]=>
  string(76) "AI innovator talks personalized treatment, telehealth enhancement and ethics"
  [2]=>
  string(150) "Dr. Renee Dua, founder of Together by Renee, a healthcare assistant app that uses generative artificial intelligence, also offers an in-depth look at "
  ["short_description"]=>
  string(150) "Dr. Renee Dua, founder of Together by Renee, a healthcare assistant app that uses generative artificial intelligence, also offers an in-depth look at "
  [3]=>
  string(215) "Dr. Renee Dua, founder of Together by Renee, a healthcare assistant app that uses generative artificial intelligence, also offers an in-depth look at how the AI in her app can help patients and their caregivers.&#nl"
  ["description"]=>
  string(215) "Dr. Renee Dua, founder of Together by Renee, a healthcare assistant app that uses generative artificial intelligence, also offers an in-depth look at how the AI in her app can help patients and their caregivers.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(113) "https://www.healthcareitnews.com/news/ai-innovator-talks-personalized-treatment-telehealth-enhancement-and-ethics"
  ["blog_url"]=>
  string(113) "https://www.healthcareitnews.com/news/ai-innovator-talks-personalized-treatment-telehealth-enhancement-and-ethics"
  [15]=>
  string(19) "2024-01-23 01:01:11"
  ["add_date"]=>
  string(19) "2024-01-23 01:01:11"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

AI innovator talks personalized treatment, telehealth enhancement and ethics

Dr. Renee Dua, founder of Together by Renee, a healthcare assistant app that uses generative artificial intelligence, al

array(40) {
  [0]=>
  string(4) "9029"
  ["article_id"]=>
  string(4) "9029"
  [1]=>
  string(61) "Healthful Plant-Based Diet May Lower Risk for Type 2 Diabetes"
  ["article_title"]=>
  string(61) "Healthful Plant-Based Diet May Lower Risk for Type 2 Diabetes"
  [2]=>
  string(150) "MONDAY, Jan. 22, 2024 -- A healthful plant-based diet may lower the risk for type 2 diabetes mellitus (T2DM), according to a study published in the Ja"
  ["short_description"]=>
  string(150) "MONDAY, Jan. 22, 2024 -- A healthful plant-based diet may lower the risk for type 2 diabetes mellitus (T2DM), according to a study published in the Ja"
  [3]=>
  string(256) "MONDAY, Jan. 22, 2024 -- A healthful plant-based diet may lower the risk for type 2 diabetes mellitus (T2DM), according to a study published in the January issue of Diabetes & Metabolism.&#nlAlysha S. Thompson, from Queen's University Belfast in..."
  ["description"]=>
  string(256) "MONDAY, Jan. 22, 2024 -- A healthful plant-based diet may lower the risk for type 2 diabetes mellitus (T2DM), according to a study published in the January issue of Diabetes & Metabolism.&#nlAlysha S. Thompson, from Queen's University Belfast in..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(96) "https://www.drugs.com/news/healthful-plant-based-diet-may-lower-risk-type-2-diabetes-117200.html"
  ["blog_url"]=>
  string(96) "https://www.drugs.com/news/healthful-plant-based-diet-may-lower-risk-type-2-diabetes-117200.html"
  [15]=>
  string(19) "2024-01-23 01:01:09"
  ["add_date"]=>
  string(19) "2024-01-23 01:01:09"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:47"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:47"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Healthful Plant-Based Diet May Lower Risk for Type 2 Diabetes

MONDAY, Jan. 22, 2024 -- A healthful plant-based diet may lower the risk for type 2 diabetes mellitus (T2DM), according 

array(40) {
  [0]=>
  string(4) "9201"
  ["article_id"]=>
  string(4) "9201"
  [1]=>
  string(100) "Online portal launched to combat urgent need for more accessible ways to identify trial participants"
  ["article_title"]=>
  string(100) "Online portal launched to combat urgent need for more accessible ways to identify trial participants"
  [2]=>
  string(150) "An online portal enabling people worldwide to find and express interest in clinical trials has been launched by Clinical Trial Media, a clinical trial"
  ["short_description"]=>
  string(150) "An online portal enabling people worldwide to find and express interest in clinical trials has been launched by Clinical Trial Media, a clinical trial"
  [3]=>
  string(197) "An online portal enabling people worldwide to find and express interest in clinical trials has been launched by Clinical Trial Media, a clinical trial participant recruitment and retention company."
  ["description"]=>
  string(197) "An online portal enabling people worldwide to find and express interest in clinical trials has been launched by Clinical Trial Media, a clinical trial participant recruitment and retention company."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(172) "https://www.outsourcing-pharma.com/Article/2024/01/22/clinical-trial-media-launches-online-portal-for-studies-and-trials?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(172) "https://www.outsourcing-pharma.com/Article/2024/01/22/clinical-trial-media-launches-online-portal-for-studies-and-trials?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-23 00:42:00"
  ["add_date"]=>
  string(19) "2024-01-23 00:42:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:49"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Online portal launched to combat urgent need for more accessible ways to identify trial pa

An online portal enabling people worldwide to find and express interest in clinical trials has been launched by Clinical

array(40) {
  [0]=>
  string(4) "9202"
  ["article_id"]=>
  string(4) "9202"
  [1]=>
  string(77) "Priory staff have more time to care thanks to Nourish digital records system "
  ["article_title"]=>
  string(77) "Priory staff have more time to care thanks to Nourish digital records system "
  [2]=>
  string(152) "A digital records system has saved Priory, the UKâs leading independent provider of mental health services, thousands of hours freeing them up for di"
  ["short_description"]=>
  string(152) "A digital records system has saved Priory, the UKâs leading independent provider of mental health services, thousands of hours freeing them up for di"
  [3]=>
  string(174) "A digital records system has saved Priory, the UKâs leading independent provider of mental health services, thousands of hours freeing them up for direct resident support."
  ["description"]=>
  string(174) "A digital records system has saved Priory, the UKâs leading independent provider of mental health services, thousands of hours freeing them up for direct resident support."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(165) "https://www.outsourcing-pharma.com/Article/2024/01/22/digital-records-system-gives-priory-staff-more-time-to-care?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(165) "https://www.outsourcing-pharma.com/Article/2024/01/22/digital-records-system-gives-priory-staff-more-time-to-care?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-23 00:14:00"
  ["add_date"]=>
  string(19) "2024-01-23 00:14:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:49"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Priory staff have more time to care thanks to Nourish digital records system

A digital records system has saved Priory, the UKâs leading independent provider of mental health services, thousands

array(40) {
  [0]=>
  string(4) "9030"
  ["article_id"]=>
  string(4) "9030"
  [1]=>
  string(72) "Risk Factor Control May Modify Link Between HIV Status and Heart Disease"
  ["article_title"]=>
  string(72) "Risk Factor Control May Modify Link Between HIV Status and Heart Disease"
  [2]=>
  string(150) "MONDAY, Jan. 22, 2024 -- Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease"
  ["short_description"]=>
  string(150) "MONDAY, Jan. 22, 2024 -- Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease"
  [3]=>
  string(253) "MONDAY, Jan. 22, 2024 -- Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.&#nlMichael J...."
  ["description"]=>
  string(253) "MONDAY, Jan. 22, 2024 -- Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.&#nlMichael J...."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(99) "https://www.drugs.com/news/risk-factor-control-may-modify-link-between-hiv-status-heart-117204.html"
  ["blog_url"]=>
  string(99) "https://www.drugs.com/news/risk-factor-control-may-modify-link-between-hiv-status-heart-117204.html"
  [15]=>
  string(19) "2024-01-23 00:01:59"
  ["add_date"]=>
  string(19) "2024-01-23 00:01:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:47"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:47"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Risk Factor Control May Modify Link Between HIV Status and Heart Disease

MONDAY, Jan. 22, 2024 -- Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV stat

array(40) {
  [0]=>
  string(4) "9031"
  ["article_id"]=>
  string(4) "9031"
  [1]=>
  string(70) "Cognitive Benefits Seen for Daily Multivitamin-Mineral Supplementation"
  ["article_title"]=>
  string(70) "Cognitive Benefits Seen for Daily Multivitamin-Mineral Supplementation"
  [2]=>
  string(150) "MONDAY, Jan. 22, 2024 -- Daily multivitamin-mineral (MVM) supplementation yields cognitive benefits, according to a study published online Jan. 18 in "
  ["short_description"]=>
  string(150) "MONDAY, Jan. 22, 2024 -- Daily multivitamin-mineral (MVM) supplementation yields cognitive benefits, according to a study published online Jan. 18 in "
  [3]=>
  string(252) "MONDAY, Jan. 22, 2024 -- Daily multivitamin-mineral (MVM) supplementation yields cognitive benefits, according to a study published online Jan. 18 in the American Journal of Clinical Nutrition.&#nlChirag M. Vyas, M.B.B.S., M.P.H., from Massachusetts..."
  ["description"]=>
  string(252) "MONDAY, Jan. 22, 2024 -- Daily multivitamin-mineral (MVM) supplementation yields cognitive benefits, according to a study published online Jan. 18 in the American Journal of Clinical Nutrition.&#nlChirag M. Vyas, M.B.B.S., M.P.H., from Massachusetts..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(105) "https://www.drugs.com/news/cognitive-benefits-seen-daily-multivitamin-mineral-supplementation-117206.html"
  ["blog_url"]=>
  string(105) "https://www.drugs.com/news/cognitive-benefits-seen-daily-multivitamin-mineral-supplementation-117206.html"
  [15]=>
  string(19) "2024-01-23 00:01:30"
  ["add_date"]=>
  string(19) "2024-01-23 00:01:30"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:47"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:47"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Cognitive Benefits Seen for Daily Multivitamin-Mineral Supplementation

MONDAY, Jan. 22, 2024 -- Daily multivitamin-mineral (MVM) supplementation yields cognitive benefits, according to a stud

array(40) {
  [0]=>
  string(4) "9180"
  ["article_id"]=>
  string(4) "9180"
  [1]=>
  string(62) "Colorcon to showcase packaging capabilities at Pharmapack 2024"
  ["article_title"]=>
  string(62) "Colorcon to showcase packaging capabilities at Pharmapack 2024"
  [2]=>
  string(150) "Colorcon, a specialist in the development and supply of film coating systems, speciality excipients and functional packaging for the healthcare indust"
  ["short_description"]=>
  string(150) "Colorcon, a specialist in the development and supply of film coating systems, speciality excipients and functional packaging for the healthcare indust"
  [3]=>
  string(224) "Colorcon, a specialist in the development and supply of film coating systems, speciality excipients and functional packaging for the healthcare industries, will be exhibiting its expanded portfolio at Pharmapack in Paris."
  ["description"]=>
  string(224) "Colorcon, a specialist in the development and supply of film coating systems, speciality excipients and functional packaging for the healthcare industries, will be exhibiting its expanded portfolio at Pharmapack in Paris."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(131) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/colorcon-to-showcase-packaging-capabilities-at-pharmapack-20/"
  ["blog_url"]=>
  string(131) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/colorcon-to-showcase-packaging-capabilities-at-pharmapack-20/"
  [15]=>
  string(19) "2024-01-22 23:27:08"
  ["add_date"]=>
  string(19) "2024-01-22 23:27:08"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:41"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Colorcon to showcase packaging capabilities at Pharmapack 2024

Colorcon, a specialist in the development and supply of film coating systems, speciality excipients and functional packa

array(40) {
  [0]=>
  string(4) "9203"
  ["article_id"]=>
  string(4) "9203"
  [1]=>
  string(90) "Bora Pharmaceuticals expands into the US for the first time with Upsher-Smith acquisition "
  ["article_title"]=>
  string(90) "Bora Pharmaceuticals expands into the US for the first time with Upsher-Smith acquisition "
  [2]=>
  string(146) "Bora Pharmaceuticals is set to acquire US pharma manufacturer Upsher-Smith Laboratories for up to $210 million, it says, to fuel global expansion."
  ["short_description"]=>
  string(146) "Bora Pharmaceuticals is set to acquire US pharma manufacturer Upsher-Smith Laboratories for up to $210 million, it says, to fuel global expansion."
  [3]=>
  string(146) "Bora Pharmaceuticals is set to acquire US pharma manufacturer Upsher-Smith Laboratories for up to $210 million, it says, to fuel global expansion."
  ["description"]=>
  string(146) "Bora Pharmaceuticals is set to acquire US pharma manufacturer Upsher-Smith Laboratories for up to $210 million, it says, to fuel global expansion."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(164) "https://www.outsourcing-pharma.com/Article/2024/01/22/upsher-smith-s-a-perfect-match-for-bora-s-long-term-growth?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(164) "https://www.outsourcing-pharma.com/Article/2024/01/22/upsher-smith-s-a-perfect-match-for-bora-s-long-term-growth?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2024-01-22 23:23:00"
  ["add_date"]=>
  string(19) "2024-01-22 23:23:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:49"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Bora Pharmaceuticals expands into the US for the first time with Upsher-Smith acquisition

Bora Pharmaceuticals is set to acquire US pharma manufacturer Upsher-Smith Laboratories for up to $210 million, it says,

array(40) {
  [0]=>
  string(4) "9219"
  ["article_id"]=>
  string(4) "9219"
  [1]=>
  string(57) "Yonsei University Hospital System kicks off DTx ecosystem"
  ["article_title"]=>
  string(57) "Yonsei University Hospital System kicks off DTx ecosystem"
  [2]=>
  string(65) "More hospitals are coming into the fold in the coming months.&#nl"
  ["short_description"]=>
  string(65) "More hospitals are coming into the fold in the coming months.&#nl"
  [3]=>
  string(65) "More hospitals are coming into the fold in the coming months.&#nl"
  ["description"]=>
  string(65) "More hospitals are coming into the fold in the coming months.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(96) "https://www.healthcareitnews.com/news/asia/yonsei-university-hospital-system-kicks-dtx-ecosystem"
  ["blog_url"]=>
  string(96) "https://www.healthcareitnews.com/news/asia/yonsei-university-hospital-system-kicks-dtx-ecosystem"
  [15]=>
  string(19) "2024-01-22 23:19:57"
  ["add_date"]=>
  string(19) "2024-01-22 23:19:57"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Yonsei University Hospital System kicks off DTx ecosystem

More hospitals are coming into the fold in the coming months.&#nl